{"entity":{"type":"insider","cik":"0001697536","url":"/insider/0001697536","json_url":"/insider/0001697536.json","name":"Romano Sarah","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":13,"first":"2017-06-14","last":"2025-01-08","span_basis":"filed_date"},"name_variants":[{"name":"Romano Sarah","source":"filing","n_filings":13,"first_seen":"2017-06-14","last_seen":"2025-01-08"}],"transactions":[{"id":4029556,"accession":"0001104659-25-002042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-002042","line_url":"/filing/0001104659-25-002042#line-1","is_derivative":false,"issuer_cik":"0001604191","issuer_name":"Entero Therapeutics, Inc.","issuer_ticker":"ENTO","issuer_name_source":null,"issuer_url":"/issuer/0001604191","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":727.0,"shares_display":"727","price_per_share":0.64,"price_display":"0.64","price_state":"stated","total_value":465.28,"total_display":"465.28","total_whole":"465","shares_owned_after":17287.0,"shares_owned_after_display":"17,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-08","scope":"insider"},{"id":3067468,"accession":"0001104659-24-107747","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-107747","line_url":"/filing/0001104659-24-107747#line-1","is_derivative":false,"issuer_cik":"0001604191","issuer_name":"Entero Therapeutics, Inc.","issuer_ticker":"ENTO","issuer_name_source":null,"issuer_url":"/issuer/0001604191","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":476.0,"shares_display":"476","price_per_share":0.446,"price_display":"0.45","price_state":"stated","total_value":212.296,"total_display":"212.30","total_whole":"212","shares_owned_after":18014.0,"shares_owned_after_display":"18,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-09","filed_date":"2024-10-10","scope":"insider"},{"id":2129355,"accession":"0001104659-24-077714","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-077714","line_url":"/filing/0001104659-24-077714#line-1","is_derivative":false,"issuer_cik":"0001604191","issuer_name":"Entero Therapeutics, Inc.","issuer_ticker":"ENTO","issuer_name_source":null,"issuer_url":"/issuer/0001604191","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":621.0,"shares_display":"621","price_per_share":1.07,"price_display":"1.07","price_state":"stated","total_value":664.47,"total_display":"664.47","total_whole":"664","shares_owned_after":18490.0,"shares_owned_after_display":"18,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-02","filed_date":"2024-07-03","scope":"insider"},{"id":2076018,"accession":"0001104659-24-043154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-043154","line_url":"/filing/0001104659-24-043154#line-1","is_derivative":false,"issuer_cik":"0001604191","issuer_name":"First Wave BioPharma, Inc.","issuer_ticker":"FWBI","issuer_name_source":null,"issuer_url":"/issuer/0001604191","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75.0,"shares_display":"75","price_per_share":4.2294,"price_display":"4.23","price_state":"stated","total_value":317.205,"total_display":"317.20","total_whole":"317","shares_owned_after":19111.0,"shares_owned_after_display":"19,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":2398316,"accession":"0001104659-24-036138","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-036138","line_url":"/filing/0001104659-24-036138#line-1","is_derivative":false,"issuer_cik":"0001604191","issuer_name":"First Wave BioPharma, Inc.","issuer_ticker":"FWBI","issuer_name_source":null,"issuer_url":"/issuer/0001604191","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1120.0,"shares_display":"1,120","price_per_share":4.96,"price_display":"4.96","price_state":"stated","total_value":5555.2,"total_display":"5,555.20","total_whole":"5,555","shares_owned_after":19186.0,"shares_owned_after_display":"19,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-15","filed_date":"2024-03-19","scope":"insider"},{"id":2599301,"accession":"0001104659-24-004460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-004460","line_url":"/filing/0001104659-24-004460#line-1","is_derivative":false,"issuer_cik":"0001604191","issuer_name":"First Wave BioPharma, Inc.","issuer_ticker":"FWBI","issuer_name_source":null,"issuer_url":"/issuer/0001604191","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98.0,"shares_display":"98","price_per_share":4.2,"price_display":"4.20","price_state":"stated","total_value":411.6,"total_display":"411.60","total_whole":"412","shares_owned_after":20306.0,"shares_owned_after_display":"20,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-12","filed_date":"2024-01-17","scope":"insider"},{"id":8202968,"accession":"0001104659-23-107483","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-107483","line_url":"/filing/0001104659-23-107483#line-1","is_derivative":false,"issuer_cik":"0001604191","issuer_name":"First Wave BioPharma, Inc.","issuer_ticker":"FWBI","issuer_name_source":null,"issuer_url":"/issuer/0001604191","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1676.0,"shares_display":"1,676","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":486.04,"total_display":"486.04","total_whole":"486","shares_owned_after":15800.0,"shares_owned_after_display":"15,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-04","filed_date":"2023-10-06","scope":"insider"},{"id":8473157,"accession":"0001104659-23-078145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-078145","line_url":"/filing/0001104659-23-078145#line-1","is_derivative":false,"issuer_cik":"0001604191","issuer_name":"First Wave BioPharma, Inc.","issuer_ticker":"FWBI","issuer_name_source":null,"issuer_url":"/issuer/0001604191","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1977.0,"shares_display":"1,977","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":3044.58,"total_display":"3,044.58","total_whole":"3,045","shares_owned_after":17476.0,"shares_owned_after_display":"17,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-05","scope":"insider"},{"id":8622786,"accession":"0001104659-23-042170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-042170","line_url":"/filing/0001104659-23-042170#line-1","is_derivative":false,"issuer_cik":"0001604191","issuer_name":"First Wave BioPharma, Inc.","issuer_ticker":"FWBI","issuer_name_source":null,"issuer_url":"/issuer/0001604191","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1975.0,"shares_display":"1,975","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":4937.5,"total_display":"4,937.50","total_whole":"4,938","shares_owned_after":19453.0,"shares_owned_after_display":"19,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":7905674,"accession":"0001144204-19-034766","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-19-034766","line_url":"/filing/0001144204-19-034766#line-3","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6584.0,"shares_display":"6,584","price_per_share":0.233,"price_display":"0.23","price_state":"stated","total_value":1534.072,"total_display":"1,534.07","total_whole":"1,534","shares_owned_after":262113.0,"shares_owned_after_display":"262,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-15","filed_date":"2019-07-15","scope":"insider"},{"id":7905672,"accession":"0001144204-19-034766","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-034766","line_url":"/filing/0001144204-19-034766#line-2","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6583.0,"shares_display":"6,583","price_per_share":0.2356,"price_display":"0.24","price_state":"stated","total_value":1550.9548,"total_display":"1,550.95","total_whole":"1,551","shares_owned_after":268697.0,"shares_owned_after_display":"268,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-12","filed_date":"2019-07-15","scope":"insider"},{"id":7905669,"accession":"0001144204-19-034766","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-034766","line_url":"/filing/0001144204-19-034766#line-1","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6583.0,"shares_display":"6,583","price_per_share":0.2406,"price_display":"0.24","price_state":"stated","total_value":1583.8698,"total_display":"1,583.87","total_whole":"1,584","shares_owned_after":275280.0,"shares_owned_after_display":"275,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-11","filed_date":"2019-07-15","scope":"insider"},{"id":5984747,"accession":"0001144204-18-021205","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-021205","line_url":"/filing/0001144204-18-021205#line-1","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":62500.0,"shares_display":"62,500","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":106863.0,"shares_owned_after_display":"106,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-17","filed_date":"2018-04-18","scope":"insider"},{"id":4237573,"accession":"0001144204-17-043873","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-043873","line_url":"/filing/0001144204-17-043873#line-1","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Interim CFO)","role_mark":"O","role_mark_label":"Officer (Interim CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":32500.0,"shares_owned_after_display":"32,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-15","filed_date":"2017-08-17","scope":"insider"},{"id":4864911,"accession":"0001144204-17-032554","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-032554","line_url":"/filing/0001144204-17-032554#line-1","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"EYEGATE PHARMACEUTICALS INC","issuer_ticker":"EYEG","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001697536","owner_name":"Romano Sarah","owner_display_name":"Romano Sarah","owner_url":"/insider/0001697536","role":"Officer (Interim CFO)","role_mark":"O","role_mark_label":"Officer (Interim CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":22500.0,"shares_owned_after_display":"22,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-14","filed_date":"2017-06-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604191","name":"Entero Therapeutics, Inc.","url":"/issuer/0001604191","role":"Officer (Chief Financial Officer)","n_filings":9,"first_seen":"2023-04-05","last_seen":"2025-01-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001372514","name":"EYEGATE PHARMACEUTICALS INC","url":"/issuer/0001372514","role":"Officer (Chief Financial Officer)","n_filings":4,"first_seen":"2017-06-14","last_seen":"2019-07-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001697536","retrieved_at":"2026-08-22T06:51:07+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}